November 12, 2025
Video
Tracy Milgram-Posner sat down for an interview with CURE to discuss BRCAStrong and the impact she hopes to make for anyone with breast cancer.
Detalimogene Shows 62% Response Rate in Bladder Cancer Trial
Tracy Milgram-Posner Discusses BRCAStrong and Breast Cancer Support
Finally Learning to Put Myself First
Experts Discuss Next Steps in Perioperative Bladder Cancer Treatment